Daniel P. Tredwell
Known title: DirectorCIK: 0001399401
Daniel P. Tredwell's purchase track record
How the stock did after each of Daniel P. Tredwell's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
14
of 16 since November 8, 2022
Stock higher 6 months later
64%
3 months: 60%
Median 6-month return
+0.9%
3 months: +1.1%
Beat the S&P 500
21%
median -9.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/12/2026 | TRS | $3K | pending | pending | — |
| 5/13/2026 | TRS | $3K | -1.8% | pending | — |
| 3/5/2026 | TRS | $2K | +2.3% | +0.5% | +13.4% |
| 11/12/2025 | TRS | $2K | +13.5% | +26.1% | +8.7% |
| 8/11/2025 | TRS | $2K | -9.2% | +3.5% | +9.3% |
| 5/12/2025 | TRS | $2K | +42.0% | +29.0% | +16.9% |
| 2/28/2025 | TRS | $106K | +28.9% | +89.3% | +8.5% |
| 11/11/2024 | TRS | $2K | -13.7% | -11.5% | -2.6% |
| 8/12/2024 | TRS | $2K | +17.3% | +1.3% | +13.5% |
| 5/10/2024 | TRS | $2K | -11.2% | +2.3% | +14.8% |
| 3/6/2024 | TRS | $251 | +8.5% | -0.9% | +8.1% |
| 11/7/2023 | TRS | $251 | +0.6% | +8.5% | +18.5% |
| 8/8/2023 | TRS | $251 | -4.7% | -4.2% | +10.1% |
| 5/11/2023 | TRS | $250 | +1.1% | -8.7% | +5.3% |
| 3/9/2023 | TRS | $121 | -3.9% | -16.8% | +13.6% |
| 11/8/2022 | TRS | $121 | +22.8% | +0.4% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TRS | ▲ Buy | Open Market | 64 | $3K | 8/12/2026 | View on chart |
| TRS | ▲ Buy | Open Market | 62 | $3K | 5/13/2026 | View on chart |
| TRS | ▲ Buy | Grant | 2,853 | $0 | 3/14/2026 | View on chart |
| TRS | ▲ Buy | Open Market | 60 | $2K | 3/5/2026 | View on chart |
| TRS | ▲ Buy | Open Market | 74 | $2K | 11/12/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 66 | $2K | 8/11/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 95 | $2K | 5/12/2025 | View on chart |
| TRS | ▲ Buy | Grant | 4,140 | $0 | 3/14/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 96 | $2K | 3/6/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 5,000 | $103K | 2/28/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 79 | $2K | 11/11/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 92 | $2K | 8/12/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 81 | $2K | 5/10/2024 | View on chart |
| TRS | ▲ Buy | Grant | 4,068 | $0 | 3/14/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 10 | $251 | 3/6/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 10 | $251 | 11/7/2023 | View on chart |
| TRS | ▲ Buy | Open Market | 10 | $251 | 8/8/2023 | View on chart |
| TRS | ▲ Buy | Open Market | 10 | $250 | 5/11/2023 | View on chart |
| TRS | ▲ Buy | Grant | 3,445 | $0 | 3/11/2023 | View on chart |
| TRS | ▲ Buy | Open Market | 4 | $121 | 3/9/2023 | View on chart |
| TRS | ▲ Buy | Open Market | 5 | $121 | 11/8/2022 | View on chart |
| TRS | ▼ Sell | Other | 4 | $121 | 8/11/2022 | View on chart |
| TRS | ▼ Sell | Other | 4 | $121 | 5/10/2022 | View on chart |
| TRS | ▲ Buy | Grant | 3,222 | $0 | 3/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
TriMas Sets Q3 2026 Earnings Call Date
TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.
TriMas Sets Q3 2026 Earnings Call Date. TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.